MedTrace Logo

Suicide Prevention in Chinese Older Adults

NCT02096432 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-12-21

No results posted yet for this study

Summary

This project aims to develop and refine a suicide intervention protocol, and pilot test a culturally tailored randomized control trial to reduce suicidal thoughts among U.S. Chinese older adults. During the first phase of the study, the investigators plan to invite the community advisory board and key stakeholders to participate in the iterative design and refinement of the study protocol. During the second phase of the project and after the initial screening and based on a specific set of inclusion criteria, the investigators will invite U.S. Chinese older adult to participate in a pilot randomized control trial of a culturally adapted intervention to reduce the frequency and intensity of suicidal thoughts in Chinese older adults. During the third phase of the project, the investigators plan to invite pilot intervention participants as well as key stakeholders and health care professionals on the cultural acceptability of the pilot intervention. Through the achievement of these objectives, the investigators will set the foundation to fully test a culturally adapted in-home intervention, which may be particularly suitable for Chinese older adults with suicidal thoughts as it addresses cultural-specific barriers and integrates care management within existing community services agencies using non-mental health professionals, including community health workers.

Conditions

Interventions

BEHAVIORAL

Behavior Activation

Behavioral Activation includes the following components: empowering education, referral to treatment, care Management, and behavior activation

BEHAVIORAL

Usual Community Care

Community standard care as usual

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • XinQi Dong, MD, MPH · Rush University Medical Center

  • Melissa A. Simon, MD, MPH · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-07-31
Completion
2018-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02096432 on ClinicalTrials.gov